Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Bristol-Myers Squibb Stock: Is BMY Outperforming the Healthcare Sector?

Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical company. With a market cap of $97.9 billion, the company engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. 

Companies worth $10 billion or more are generally described as “large-cap stocks”, and Bristol-Myers Squibb fits this description perfectly. The company portfolio includes key therapies in oncology, immunology, cardiovascular, and hematology. It also continues to expand its pipeline through internal R&D and strategic acquisitions.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.